BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 33155133)

  • 21. High-throughput liquid chromatography/electrospray ionization-tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma.
    Hirasawa T; Kikuchi M; Shigeta K; Takasaki S; Sato Y; Sato T; Ogura J; Onodera K; Fukuhara N; Onishi Y; Maekawa M; Mano N
    Biomed Chromatogr; 2021 Aug; 35(8):e5124. PubMed ID: 33772839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
    Pressiat C; Huynh HH; Plé A; Sauvageon H; Madelaine I; Chougnet C; Le Maignan C; Mourah S; Goldwirt L
    Ther Drug Monit; 2018 Jun; 40(3):337-343. PubMed ID: 29474275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study.
    Ezzeldin E; Iqbal M; Herqash RN; ElNahhas T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121851. PubMed ID: 31812004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
    Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N
    J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous determination of a p38 MAP kinase inhibitor and its amide hydrolyzed metabolite in Cynomolgus monkey plasma by LC-MS/MS, and its application to a toxicokinetic study.
    Akrami A; Hsieh F; Almon V; Bruenner BA; James C; Wong P
    J Pharm Biomed Anal; 2011 Jul; 55(5):1104-10. PubMed ID: 21481559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
    Maher HM; Alzoman NZ; Shehata SM
    J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Macwan JS; Ionita IA; Dostalek M; Akhlaghi F
    Anal Bioanal Chem; 2011 Apr; 400(2):423-33. PubMed ID: 21359569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Olorofim (F901318), a Novel Antifungal Drug, in Human Plasma and Serum.
    Müller C; Fietz C; Koehler P; Sibley G; Nforbugwe ACA; Streichert T; Wiesen MHJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
    Couchman L; Birch M; Ireland R; Corrigan A; Wickramasinghe S; Josephs D; Spicer J; Flanagan RJ
    Anal Bioanal Chem; 2012 Jun; 403(6):1685-95. PubMed ID: 22526649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatography-tandem mass spectrometric assay for the tyrosine kinase inhibitor afatinib in mouse plasma using salting-out liquid-liquid extraction.
    Sparidans RW; van Hoppe S; Rood JJ; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():118-23. PubMed ID: 26826475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
    Yamada E; Takagi R; Sudo K; Kato S
    J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections.
    LLopis B; Funck-Brentano C; Tissot N; Bleibtreu A; Jaureguiberry S; Fourniols E; Aubry A; Zahr N
    J Pharm Biomed Anal; 2020 May; 183():113137. PubMed ID: 32086125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
    Giri P; Joshi V; Giri S; Delvadia P; Jain MR
    Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the tyrosine kinase inhibitor pazopanib in human plasma.
    Sparidans RW; Ahmed TT; Muilwijk EW; Welzen ME; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():137-40. PubMed ID: 22917595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
    Zhao M; Rudek MA; He P; Hafner FT; Radtke M; Wright JJ; Smith BD; Messersmith WA; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):1-7. PubMed ID: 16798122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Macwan JS; Ionita IA; Akhlaghi F
    Anal Bioanal Chem; 2012 Jan; 402(3):1217-27. PubMed ID: 22108655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid chromatography-tandem mass spectrometric assay for the JAK2 inhibitor CYT387 in plasma.
    Sparidans RW; Durmus S; Xu N; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():174-7. PubMed ID: 22476054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.
    Li B; Wang J; Dou X; Zhang X; Xue X; Xu Q; Ran W; Xiong S
    Comb Chem High Throughput Screen; 2021; 24(9):1410-1416. PubMed ID: 33155888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a sensitive simultaneous LC-MS/MS method for the quantification of novel anti-cancer thiazolidinedione and quinazolin-4-one derivatives in rat plasma and its application in a rat pharmacokinetic study.
    Sengottuvelan S; Uppal R; Vuppu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():18-27. PubMed ID: 31082683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.